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The incidence of renal tumors has increased during the
past two decades. This is probably due to the in-
creased use of abdominal ultrasound and computed
tomography for abdominal diseases [1]. Incidental
renal tumors are smaller and less likely to metasta-
size [2]. Therefore, surgical treatment of renal tumors
has developed towards conservative surgery of the
renal parenchyma and the use of minimally invasive
techniques. During the past decade, partial nephrec-
tomy has been accepted as an effective and safe alter-
native to radical nephrectomy for small renal cortical
tumors [3] which is a well-known surgical procedure
that may cause major bleeding. Hemostatic agents
have an important role during open partial ne-
phrectomy. Many of them have been reported to stop
hemorrhage as renal parenchymal hemostatic aids,
glues and other substances [4].
Ankaferd BloodStopper (ABS) is a unique folk-
loric medicinal plant extract, which has historically
been used in Turkish traditional medicine as a hemo-
static agent. ABS has some effects on the endothe-
lium, blood cells, angiogenesis, cellular proliferation,
vascular dynamics and cell mediators [5]. In this case
study, we evaluated the hemostatic effect of local
ABS application in a patient who underwent open
partial nephrectomy.
CASE PRESENTATION
A 72-year-old man presented to the outpatient clinic
with dull aching pain in the right loin. Disease-specific
history taking, physical examination, and blood and
urine analysis were performed. The pain pattern was
intermittent. He had no lower urinary tract symptoms,
hematuria or fever. Physical examination revealed a
normal abdomen and external genitalia. Blood and
urine analyses were normal. Urinary ultrasound and
computed tomography showed a 42 × 36 mm exo-
phytic mass at the lower pole of right kidney (Figure 1).
Open partial nephrectomy was performed. We inves-
tigated the effect of ABS as a hemostatic agent during
the procedure. The patient gave signed informed
consent that authorized us to use ABS during the
procedure.
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Open partial nephrectomy is an effective and safe alternative treatment modality to radical
nephrectomy for small renal tumors. Many techniques that use hemostatic agents have been
described to provide hemostasis during this procedure. Ankaferd BloodStopper® (ABS) is a
unique folkloric medicinal plant extract that has been used historically in Turkish traditional
medicine as a hemostatic agent. ABS has therapeutic potential to manage hemorrhage and this
agent should be investigated in clinical trials. In the present case, we evaluated the effectiveness
of ABS in partial nephrectomy and reviewed the literature.
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A flank incision approach was used for opening
Gerota’s fascia onto the site of the tumor and localiz-
ing the kidney and the tumor. Warm ischemia was not
performed for this lesion. The tumor was resected with
a safety margin of 5 mm of healthy renal parenchyma.
Total resection of the tumor was completed without
recourse to any type of renal ischemia. An intraoper-
ative frozen section biopsy of the tumor bed was per-
formed. ABS tampons 5 × 7 cm (including 10 mL ABS
solution) were used to provide hemostasis. The ap-
plication was performed by compressing the ABS
tampon onto the bleeding region for at least 2 min-
utes (Figure 2). Following excision of the renal lesion,
major bleeding was observed from the base of the
excised renal mass. An ABS tampon was immediately
compressed onto the bleeding area until the bleeding
stopped. During compression, 5 mL of adjuvant ABS
solution was added to the tampon manually. The ABS
tampons are non-absorbent; therefore, we had to
remove the tampon when the bleeding stopped. While
performing partial nephrectomy, only monopolar cau-
terization was applied to the minor bleeding points.
No additional hemostatic agent was used. Allergic
reaction, acute toxicity, complications and renal tis-
sue injury were not observed perioperatively. We
found that a well-compressed ABS tampon was suffi-
cient to achieve hemostasis. The operation time was
100 minutes. The amount of blood loss was nearly
300mL. No blood transfusion was required. The patho-
logical examination report was renal cell carcinoma,
conventional type Fuhrman grade II. No postopera-
tive complication was detected at the first month of
follow-up.
DISCUSSION
Radical nephrectomy is the standard treatment for lo-
calized unilateral renal tumors, with a normally func-
tioning contralateral kidney [6]. However, recent data
have suggested that partial nephrectomy has become
the gold standard for renal tumors ≤ 4 cm, with de-
monstrated oncological and improved renal functional
outcomes that are similar to those of radical nephrec-
tomy [7]. Injury to adjacent organs, major vessel and
vascular injury, and hemorrhage are some of the com-
plications of this procedure that might necessitate
transfusion [8]. As a result of the risk of bleeding, pro-
viding hemostasis is important for this procedure. In
partial nephrectomy, there might also be a risk of renal
dysfunction if a vascular clamp is used for control of
bleeding. The development of surgical tools and min-
imally invasive techniques that allow bloodless and
non-traumatic resection of the renal parenchyma make
it possible to perform partial nephrectomy without
clamping the renal pedicle. Many techniques to pro-
vide hemostasis in partial nephrectomy have been de-
veloped, such as intracorporeal suturing, microwave
Figure 1. Preoperative computed tomography showed a 42×36mm
exophytic right renal mass at the lower pole.
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Figure 2. Intraoperative application of Ankaferd BloodStopper tampons.
tissue coagulation, spray coagulation, application of
fibrinogen hemostatic patches, and hemostatic agents.
Here, we studied the role of the hemostatic agent ABS
in partial nephrectomy.
ABS is composed of a mixture of five plants,
including 5 mg Thymus vulgaris, 9 mg Glycyrrhiza
glabra, 8 mg Vitis vinifera, 7 mg Alpinia officinarum and
6 mg Urtica dioica in 100 mL Ankaferd solution. The
basic ABS mechanism of action is the formation of an
encapsulated protein network that provides focal
points for vital erythrocyte aggregation. The protein
network induced by ABS forms rapidly (< 1 sec).
However, blood cells, particularly erythrocytes, par-
ticipate in protein network formation. It has been
shown that the ABS-induced protein network is capa-
ble of regulating further coagulation and hemostatic
reactions [5].
ABS is a licensed medicinal plant product that
provides active hemostasis in external, postoperative
and dental bleeding and is approved in Turkey by
the Ministry of Health. The use of ABS for internal
organ hemorrhage is under investigation [5]. After
studying the effects of ABS in an experimental con-
trolled trial of rat partial nephrectomy [9], the first
clinical application of ABS in a urological procedure
was made by our clinic in radical retropubic prostatec-
tomy [10]. Additionally, this is believed to be the first
case to evaluate the efficacy of ABS in open partial
nephrectomy.
Several hemostatic agents have been investigated
for their potential for managing vascular injury, and
many have also been evaluated for their efficacy for
repairing collecting duct injury. Pursifull and Morey
have reviewed the use of fibrin sealant and gelatin
matrix, and Desai et al and Gill et al studied the effec-
tiveness of gelatin matrix in open and laparoscopic
partial nephrectomy models [11–13]. Recent studies
have shown the potential efficacy of these materials
for decreasing hemorrhage.
We observed that ABS was successfully applied to
stop bleeding without suturing the renal paren-
chyma, and this application on the transected kidney
area provided active hemostasis in partial nephrec-
tomy. In our opinion, ABS has a major effect on active
hemostasis during partial nephrectomy. However,
major bleeding from renal tissue could be controlled
with extra doses of ABS solution, which were applied
to the bleeding area. We suggest this application
method to provide active hemostasis in renal tissue.
In our opinion, the observation of ineffective hemo-
stasis with ABS will be the main reason to provide
hemostasis with traditional methods such as sutur-
ing and monopolar cautery. However, randomized,
controlled, double-blind clinical trials to investigate
the hemostatic effect of ABS in renal bleeding need to
be designed.
REFERENCES
1. Janzen NK, Kim HL, Figlin RA, et al. Surveillance after
radical or partial nephrectomy for localized renal cell
carcinoma and management of recurrent disease. Urol
Clin North Am 2003;30:843–52.
2. Patard JJ, Dorey FJ, Cindolo L, et al. Symptoms as well
as tumor size provide prognostic information on
patients with localized renal tumors. J Urol 2004;172:
2167–71.
3. Novick AC, Campbell SC. ‘Tumores renales’. In: Walsh
PC, et al., eds. Campbell’s Urology. Buenos Aires: Editorial
Panamericana, 2005:2911–79.
4. Thompson T, Chi-Fai N, Tolley D. Renal parenchymal
hemostatic aids: glues and things. Curr Opin Urol 2003;
13:209–14.
5. Göker H, Haznedaroğlu IC, Erçetin S, et al. Haemostatic
actions of the folkloric medicinal plant extract Ankaferd
BloodStopper. J Int Med Res 2008;36:163–70.
6. Lee CT, Katz J, Shi W, et al. Surgical management of
renal tumors 4 cm or less in a contemporary cohort. 
J Urol 2000:163:730–6.
7. Van Poppel H, Bamelis B, Oyen R, et al. Partial
nephrectomy for renal cell carcinoma can achieve long-
term tumor control. J Urol 1998;160:674–8.
8. Campbell SC, Novick AC, Streem SB, et al. Complica-
tions of nephron sparing surgery for renal tumors. 
J Urol 1994;151:1177–80.
9. Huri E, Akgül T, Ayyıldız A, et al. Hemostatic role of a
folkloric medicinal plant extract in a rat partial
nephrectomy model: controlled experimental trial. J Urol
2009;181:2349–54.
10. Huri E, Akgül T, Ayyıldız A, et al. Hemostasis in radi-
cal retropubic prostatectomy with Ankaferd Blood-
Stopper: a case report. Kaohsiung J Med Sci 2009;25:
445–7.
11. Pursifull NF, Morey AF. Tissue glues and nonsuturing
techniques. Curr Opin Urol 2007;17:396–401.
12. Desai PJ, Maynes LJ, Zuppan C, et al. Hand assisted
laparoscopic partial nephrectomy in the porcine model
using gelatin matrix hemostatic sealant without hilar
occlusion. J Endourol 2005;19:566–9.
13. Gill IS, Ramani AP, Spaliviero M, et al. Improved
hemostasis during laparoscopic partial nephrectomy
using gelatin matrix thrombin sealant. Urology 2005;65:
463–6.
Ankaferd BloodStopper in partial nephrectomy
Kaohsiung J Med Sci September 2010 • Vol 26 • No 9 495
